Prediction of outcomes and response to treatments with an ultrasensitive method for assessing intratumor epigenetic heterogeneity in colorectal cancer

ABSTRACT: Primary outcome(s): The detection rates of epigenetic heterogeneity in primary tumor and plasma from colorectal cancer patients with Methylation-sensitive high resolution melt(MS-HRM).

DISEASE(S): Colorectal Cancer

PROVIDER: 2636460 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR